Ovarian Cancer: Frontline Therapy - Episode 5

Selecting a PARP Inhibitor for Front Line Maintenance in Advance Ovarian Cancer

April 15, 2021
Rebecca Previs, MD

Dr. Rebecca Previs discusses the role of PARP inhibitors in first line maintenance therapy in advanced ovarian cancer.